Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl

NCT00532168 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

108

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: tenofovir + emtricitabine + efavirenz
DRUG: tenofovir + emtricitabine + lopinavir-ritonavir
DRUG: tenofovir + emtricitabine + atazanavir-ritonavir

Sponsor

Juan A. Arnaiz